SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction Combination Will Create a Diversified Leader in Life Sciences Tools BOULDER, Colo., Jan. 4, 2024 /PRNewswire/ — SomaLogic, Inc. (Nasdaq: SLGC) (“the Company”), a leader in proteomics…

Click here to view original post